dc.contributor.author | Bol, KF | |
dc.contributor.author | van den Bosch, T | |
dc.contributor.author | Schreibelt, G | |
dc.contributor.author | Mensink, HW | |
dc.contributor.author | Keunen, JEE | |
dc.contributor.author | Kiliç, E | |
dc.contributor.author | Japing, WJ | |
dc.contributor.author | Geul, KW | |
dc.contributor.author | Westdorp, H | |
dc.contributor.author | Boudewijns, S | |
dc.contributor.author | Croockewit, SAJ | |
dc.contributor.author | van Rossum, MM | |
dc.contributor.author | de Goede, AL | |
dc.contributor.author | Naus, NC | |
dc.contributor.author | van der Graaf, WTA | |
dc.contributor.author | Gerritsen, WR | |
dc.contributor.author | de Klein, A | |
dc.contributor.author | Punt, CJA | |
dc.contributor.author | Figdor, CG | |
dc.contributor.author | Cohen, VM | |
dc.contributor.author | Paridaens, D | |
dc.contributor.author | de Vries, IJM | |
dc.date.accessioned | 2016-12-19T15:02:27Z | |
dc.date.issued | 2016-10 | |
dc.identifier.citation | Ophthalmology, 2016, 123 (10), pp. 2265 - 2267 | |
dc.identifier.issn | 0161-6420 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/340 | |
dc.identifier.eissn | 1549-4713 | |
dc.identifier.doi | 10.1016/j.ophtha.2016.06.027 | |
dc.format | Print-Electronic | |
dc.format.extent | 2265 - 2267 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.subject | Dendritic Cells | |
dc.subject | CD8-Positive T-Lymphocytes | |
dc.subject | Humans | |
dc.subject | Melanoma | |
dc.subject | Uveal Neoplasms | |
dc.subject | Monophenol Monooxygenase | |
dc.subject | Cancer Vaccines | |
dc.subject | Disease-Free Survival | |
dc.subject | Vaccination | |
dc.subject | Survival Rate | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Middle Aged | |
dc.subject | Female | |
dc.subject | Male | |
dc.subject | gp100 Melanoma Antigen | |
dc.title | Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2016-06-06 | |
rioxxterms.versionofrecord | 10.1016/j.ophtha.2016.06.027 | |
rioxxterms.licenseref.startdate | 2016-10 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Ophthalmology | |
pubs.issue | 10 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma | |
pubs.publication-status | Published | |
pubs.volume | 123 | en_US |
pubs.embargo.terms | Not known | |
icr.researchteam | Clinical and Translational Sarcoma | en_US |
dc.contributor.icrauthor | van der Graaf, Wilhelmina | |